(Q42487519)

1 November 2017

Exercise increases plasma levels of sphingoid base-1 phosphates in humans (English)

1 reference

1 November 2017

M Baranowski

1

1 reference

1 November 2017

M Charmas

series ordinal

2

1 reference

1 November 2017

B Długołęcka

series ordinal

3

1 reference

1 November 2017

J Górski

series ordinal

4

1 reference

1 November 2017

28 May 2011

1 reference

1 November 2017

1 reference

1 November 2017

203

1 reference

1 November 2017

3

1 reference

1 November 2017

373-380

1 reference

Sphingolipid signalling in the cardiovascular system: good, bad or both?

1 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Sphingosine 1-phosphate-related metabolism in the blood vessel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Effect of exercise duration on ceramide metabolism in the rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Bioactive sphingolipids: metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Effect of exercise duration on the key pathways of ceramide metabolism in rat skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Healthy hearts--and the universal benefits of being physically active: physical activity and health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Sphingosine in apoptosis signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Erythrocytes store and release sphingosine 1-phosphate in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Exercise and training effects on ceramide metabolism in human skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Physiological and pathological actions of sphingosine 1-phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

HDL lipids and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Sphingosine kinase and sphingosine 1-phosphate in cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Metabolic signatures of exercise in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Roles of bioactive sphingolipids in cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Functions of a new family of sphingosine-1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Brachial artery blood flow responses to different modalities of lower limb exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Vascular endothelium as a contributor of plasma sphingosine 1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Ceramide and other sphingolipids in cellular responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Plasma sphingosine 1-phosphate metabolism and analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02322.X

10.1111/J.1748-1716.2011.02322.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference